Cibus Inc
CBUS
NASDAQ
Biotechnology
$1.77
USD
-0.13 (-6.84%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $148.47M
Volume 331.9K
Revenue
$4.29M
TTM
-9.8%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-104.03M
TTM
+65.9%
YoY
Operating Cash Flow
$-50.25M
TTM
+10.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 1.0 | 0.9 | 0.6 | 1.1 | 1.7 |
YoY Growth | +89.7% | +11.3% | -63.1% | -12.8% | +62.6% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 1.0 | 0.9 | 0.6 | 1.1 | 1.7 |
Selling, General & Administrative | 9.9 | 6.7 | 5.3 | 5.1 | 5.1 |
Other Operating Expenses | 21.0 | 0.0 | 0.0 | 9.1 | 0.0 |
Total Operating Expenses | 42.6 | 18.9 | 16.1 | 23.6 | 13.8 |
Operating Income | -41.6 | -17.9 | -15.4 | -22.6 | -12.1 |
EBITDA | -19.0 | -16.4 | -14.0 | -12.2 | -10.9 |
Other Income / Expense | 0.4 | -0.0 | 0.0 | -0.0 | -0.0 |
Total Other Income / Expense | -7.8 | -8.6 | -8.9 | -9.4 | -9.1 |
Income Before Income Taxes | -49.4 | -26.5 | -24.3 | -31.9 | -21.2 |
Income Taxes | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 |
Net Income | -49.4 | -26.6 | -24.3 | -31.9 | -21.2 |
Consolidated Net Income / Loss | -49.4 | -26.6 | -24.3 | -31.9 | -21.2 |
Net Income Attributable to Common Shareholders | -46.9 | -25.4 | -23.5 | -31.3 | -21.2 |
Basic EPS | -$1.34 | -$0.61 | -$0.44 | -$0.59 | -$0.33 |
Diluted EPS | -$1.34 | -$0.61 | -$0.44 | -$0.59 | -$0.33 |
Basic Shares Outstanding | 35.1M | 41.6M | 52.9M | 53.4M | 65.2M |
Diluted Shares Outstanding | 35.1M | 41.6M | 52.9M | 53.4M | 65.2M |